Benlysta SC is the first self-injection lupus treatment that can administered at home once per week.
On June 27, nearly 200 lupus activists from across the country will visit Capitol Hill and thousands more will join virtually.
We are committed to pushing the boundaries of scientific investigation and rallying stakeholders to channel resources toward research until we reach our vision of a life free of lupus.
Critical vote is big step toward establishing research program at DoD to help solve cruel mystery of lupus.
Aurinia Pharmaceuticals has announced top line results from a Phase IIb clinical study of volclosporin for the treatment of lupus nephritis.
A patient tool to help you better organize your prescription information.
Research!America has chosen the Foundation as the recipient of the Paul G. Rogers Distinguished Organization Advocacy Award.
The Pharmaceutical Research and Manufacturers of America's Medicines in Development Report cites 39 medicines in development for lupus.